APPROACH Study
Mosaic Design
APPROACH, a preventive vaccine study, seeks to address more than one clade
by Jeannie Wraight
Over the past thirty-plus years, strategies such as Treatment as...
Broadly Neutralizing Antibodies
Another Road
Broadly neutralizing antibodies aim for a diverse effect against HIV types
by Jeannie Wraight and David Miller
Broadly neutralizing antibodies (bNAbs) hold the potential of...
Toxoplasmosis & HIV
A new study published in the Journal of Immunology suggests that co-infection with toxoplasmosis (toxo), a parasitic infection common in people with AIDS, may...
Cure Research: CROI 2018
Fast Look
Cure research highlights from CROI 2018
by Jeannie Wraight
The Conference on Retroviruses and Opportunistic Infections (CROI) provides an annual snapshot of the year’s most...
Questioning the Cure
When first discussing the potential of writing a monthly column on HIV cure, my editor here at A&U Magazine asked a very valid question....
Imbokodo Study Launches
The Strength of Women
The Imbokodo Study launches in Southern Africa
by Jeannie Wraight
In Zulu, the word “Imbokodo” means “rock” and is part of a well-known...
Why We Need a Vaccine
As with any viral outbreak, the two main goals from Day One of the known HIV epidemic/pandemic have been controlling the spread of the...
Novel Cure Research Supported by amfAR
Deciphering the Puzzle
A new round of amfAR's Countdown to a Cure initiative grants support novel cure research
by Jeannie Wraight
amfAR has awarded a new round...
ABX 464 Aims to Reduce HIV Reservoirs
Revving Up
Investigational agent ABX 464 seeks to reduce HIV reservoirs
by Jeannie Wraight
ABX 464 is making its way through clinical trials, showing strong potential as...
PaxVax’s Vaccine Platform & Other Research Build Momentum
Gaining Momentum
HIV vaccine candidates seek to make good on their early promise
by Jeannie Wraight and David Miller
Over the past several years, momentum for the...